Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised the selling shareholders in this transaction. Freshfields Bruckhaus Deringer LLP and Bär & Karrer advised ZAPI Group on the deal. Forestay Capital...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Freshfields Bruckhaus Deringer LLP, Withers, advised on the matter. Freshfields Bruckhaus Deringer LLP advised Public Investment Fund with a team including Luigi Verga (Corporate...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Freshfields Bruckhaus Deringer LLP, Giliberti Triscornia e Associati, GR Legal, Legance, advised on the matter. Freshfields Bruckhaus Deringer LLP advised Fosun Fashion Group with...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Chiomenti, Freshfields Bruckhaus Deringer LLP, Norton Rose Fulbright, advised on the matter. Chiomenti advised EI Towers, F2i SGR with a team including Marco Paruzzolo...
You must be a Standard 1 Year member to access this content.
